225 Users Online
DNA ligase Market Segmented By Therapy type such as Animals, Plants and Micro-organisms with Application in Cloning, Mutation Detection, Next Generation Sequencing, Drug Target
DNA ligase offers a connection between two strands of DNA by creating a bond between the deoxyribose group of one strand and the phosphate group on another. DNA ligase is an enzyme whereas during DNA replication there is the formation of lagging strand on which Okazaki fragments are presents separately and DNA ligase utilize to gather that fragments.
A shrill trend in the application of DNA ligase is to recover the loss or rearrangement of genetic information which will propel the growth of the DNA ligase market. The incorporation of DNA ligase in infectious diseases is indirectly propelling the demand of the DNA ligase market.
DNA ligase market is expanding vastly as DNA ligases are widely utilized in numerous fields such as genetic engineering, research laboratories of molecular biology, DNA sequencing technologies and others.
The emerging demand for DNA ligase market is largely arising from the development in ligases as targets for therapeutic intervention. The major driving factor for DNA ligase market is growing inclination towards research activities across the globe for various infectious diseases.
Increasing incidence of birth genetic disorders coupled with developed technologies about repairing and replication of DNA strands will drive and boost the growth of DNA ligase market. The endlessly rising application of DNA ligase in recombinant DNA experiments and molecular biology experiments are fueling the demand for DNA ligase market.
Moreover, it is used in mutation detection, cloning, gene synthesis, and next-generation sequencing due to these consequently increase in demand for DNA ligase market. However, the high sensitivity of enzymes to pH & temperature is anticipated to restrain the growth of the DNA ligase market.
Some of the major key players competing in the global DNA ligase Market are Thermo Fisher Scientific, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Promega Corporation, New England Biolabs, Merck & Co., Amano Enzyme, BASF SE, Novozymes A/S, and Codexis, Inc. among others.